## Consolidated Statement of Cash Flows

**Year Ended** *(In millions, except shares and per share data)*

|  | Sep 28, 2024 | Sep 30, 2023 | Sep 24, 2022 |
| --- | --- | --- | --- |
|   Cash, cash equivalents, and restricted cash and cash equivalents, ending balances |  |  |  |
| **  Operating activities:** |  |  |  |
|     Net Income | $93,736 | $96,995 | $99,803 |
| *      Retained earnings/(Accumulated deficit)* | $93,736 | $96,995 | $99,803 |
| **    Adjustments to reconcile net income to cash generated by operating activities:** |  |  |  |
|       Depreciation and amortization | $11,445 | $11,519 | $11,104 |
|       Share-based compensation expense | $11,688 | $10,833 | $9,038 |
|       Other | $(2,266) | $(2,227) | $1,006 |
| **      Changes in operating assets and liabilities:** |  |  |  |
|         Accounts receivable, net | $(3,788) | $(1,688) | $(1,823) |
|         Vendor non-trade receivables | $(1,356) | $1,271 | $(7,520) |
|         Inventories | $(1,046) | $(1,618) | $1,484 |
|         Other current and non-current assets | $(11,731) | $(5,684) | $(6,499) |
|         Accounts payable | $6,020 | $(1,889) | $9,448 |
|         Other current and non-current liabilities | $15,552 | $3,031 | $6,110 |
|     Net Cash from Operating Activities | $118,254 | $110,543 | $122,151 |
| **  Investing activities:** |  |  |  |
|     Purchases of marketable securities | $(48,656) | $(29,513) | $(76,923) |
|     Proceeds from Maturities, Prepayments and Calls of Securities | $51,211 | $39,686 | $29,917 |
|     Proceeds from Sale of Debt Securities,  | $11,135 | $5,828 | $37,446 |
|     Payments for Property, Plant and Equipment | $(9,447) | $(10,959) | $(10,708) |
|     Other | $(1,308) | $(1,337) | $(2,086) |
|     Net Cash from Investing Activities | $2,935 | $3,705 | $(22,354) |
| **  Financing activities:** |  |  |  |
|     Tax Withholding for Share-Based Compensation | $(5,441) | $(5,431) | $(6,223) |
| *      Restricted stock units* | $(5,600) | $(5,600) | $(6,400) |
|     Payments of Dividends | $(15,234) | $(15,025) | $(14,841) |
|     Repurchases of common stock | $(94,949) | $(77,550) | $(89,402) |
|     Proceeds from Issuance of Long-Term Debt |  | $5,228 | $5,465 |
|     Repayments of term debt | $(9,958) | $(11,151) | $(9,543) |
|     Proceeds from (Repayments of) Commercial Paper | $3,960 | $(3,978) | $3,955 |
|     Other | $(361) | $(581) | $(160) |
|     Net Cash from Financing Activities | $(121,983) | $(108,488) | $(110,749) |
|   Net Change in Cash | $(794) | $5,760 | $(10,952) |
|   Cash, cash equivalents, and restricted cash and cash equivalents, ending balances |  |  |  |
| **  Supplemental cash flow disclosure:** |  |  |  |
|     Income Tax Expense | $26,102 | $18,679 | $19,573 |